1.33
Casi Pharmaceuticals Inc 주식(CASI)의 최신 뉴스
CASI Pharmaceuticals to Participate at Guggenheim Healthcare Innovation Conference - ACCESS Newswire
CASI (NASDAQ: CASI) fireside chat Nov 12 at Guggenheim Healthcare Innovation Conf. Boston - Stock Titan
Is CASI Pharmaceuticals Inc. stock a top momentum playQuarterly Earnings Summary & Weekly Return Optimization Alerts - newser.com
Is CASI Pharmaceuticals Inc. stock gaining market sharePortfolio Update Report & Long-Term Safe Investment Plans - newser.com
How to read the order book for CASI Pharmaceuticals Inc.2025 Big Picture & Precise Entry and Exit Recommendations - newser.com
Using data models to predict CASI Pharmaceuticals Inc. stock movementJuly 2025 Snapshot & AI Forecasted Stock Moves - newser.com
CASI Pharmaceuticals Announces Upcoming Presentation of Clinical Results for CID-103 at the 67th American Society of Hematology (ASH) Annual Meeting - Corsicana Daily Sun
CASI Pharmaceuticals (NASDAQ: CASI) to present CID-103 ITP Phase 1 poster at ASH on Dec 7 - Stock Titan
What MACD and RSI say about CASI Pharmaceuticals Inc.Quarterly Earnings Summary & Free Accurate Trade Setup Notifications - newser.com
Can CASI Pharmaceuticals Inc. stock resist sector downturnsM&A Rumor & Safe Entry Point Identification - newser.com
Smart tools for monitoring CASI Pharmaceuticals Inc.’s price actionJuly 2025 Short Interest & Fast Moving Stock Watchlists - newser.com
How resilient is CASI Pharmaceuticals Inc. stock in market downturnsMarket Performance Report & Long-Term Capital Growth Ideas - newser.com
How CASI Pharmaceuticals Inc. stock performs in weak economyWeekly Earnings Recap & Expert Approved Trade Ideas - newser.com
Can CASI Pharmaceuticals Inc. stock deliver sustainable ROELayoff News & Real-Time Volume Analysis Alerts - newser.com
Will CASI Pharmaceuticals Inc. stock attract more institutional investorsJuly 2025 Reactions & Long-Term Growth Plans - newser.com
CASI Pharmaceuticals Forms Death Cross, Signaling Potential Bearish Trend - Markets Mojo
Is CASI Pharmaceuticals Inc. stock attractive for passive investorsMarket Activity Summary & Safe Entry Point Alerts - newser.com
CASI Pharmaceuticals Forms Golden Cross, Signaling Potential Bullish Breakout - Markets Mojo
Anti-CD38 Antibody Clinical, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | I-MAB Biopharma, Takeda, HLX15, Ancora Biotech, CASI Pharmaceuticals - Barchart.com
자본화:
|
볼륨(24시간):